Management of cytomegalovirus in adult solid organ transplant patients: GESITRA-IC-SEIMC, CIBERINFEC, and SET recommendations update
Open Access
- 6 August 2024
- journal article
- review article
- Published by Elsevier in Transplantation Reviews
- Vol. 38 (4) , 100875
Abstract
No abstract availableKeywords
Funding Information
- Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica
This publication has 191 references indexed in Scilit:
- Letermovir vs Valganciclovir for Prophylaxis of Cytomegalovirus in High-Risk Kidney Transplant RecipientsJAMA, 2023
- Comparison of Three Renal Function Formulas for Ganciclovir/Valganciclovir Dose Individualization in CMV-Infected Solid Organ Transplantation Patients Using a Population ApproachClinical Pharmacokinetics, 2023
- mRNA vaccines: The future of prevention of viral infections?Journal of Medical Virology, 2023
- New Insights on CMV Management in Solid Organ Transplant Patients: Prevention, Treatment, and Management of Resistant/Refractory DiseaseInfectious Diseases and Therapy, 2022
- Cytomegalovirus mismatch after heart transplantation: Impact of antiviral prophylaxis and intravenous hyperimmune globulinImmunity, Inflammation and Disease, 2021
- Maintenance immunosuppression in heart transplantation: insights from network meta-analysis of various immunosuppression regimensHeart Failure Reviews, 2020
- Effect of Preemptive Therapy vs Antiviral Prophylaxis on Cytomegalovirus Disease in Seronegative Liver Transplant Recipients With Seropositive DonorsJAMA, 2020
- Advances in the genotypic diagnosis of cytomegalovirus antiviral drug resistanceAntiviral Research, 2020
- Clinical development of letermovir and maribavir: Overview of human cytomegalovirus drug resistanceAntiviral Research, 2019
- Analysis of spontaneous resolution of cytomegalovirus replication after transplantation in CMV-seropositive patients with pretransplant CD8+IFNG+ responseAntiviral Research, 2018